High‐dose proton therapy and carbon‐ion therapy for stage I nonsmall cell lung cancer

A study was undertaken to evaluate the clinical outcome of particle therapy for stage I nonsmall cell lung cancer (NSCLC).

[1]  H. Igaki,et al.  A case of hepatocellular carcinoma initially treated by carbon ions, followed by protons for marginal recurrence with portal thrombus. , 2005, Radiation Medicine.

[2]  Jan Nyman,et al.  Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  H. Yamashita,et al.  Extended collimator model for pencil-beam dose calculation in proton radiotherapy , 2006, Physics in medicine and biology.

[4]  M. Torikoshi,et al.  Computational modeling of beam-customization devices for heavy-charged-particle radiotherapy , 2007, Physics in medicine and biology.

[5]  Yoshiya Furusawa,et al.  Biological gain of carbon-ion radiotherapy for the early response of tumor growth delay and against early response of skin reaction in mice. , 2005, Journal of radiation research.

[6]  Kenji Eguchi,et al.  A Japanese Lung Cancer Registry Study: Prognosis of 13,010 Resected Lung Cancers , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[7]  M. Mehta,et al.  Dose coverage beyond the gross tumor volume for various stereotactic body radiotherapy planning techniques reporting similar control rates for stage I non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.

[8]  G Kraft,et al.  The radiobiological and physical basis for radiotherapy with protons and heavier ions. , 1990, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[9]  Hiroki Shirato,et al.  STEREOTACTIC RADIATION THERAPY WORKSHOP Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study , 2007 .

[10]  T. Hashimoto,et al.  Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study. , 2007, International journal of radiation oncology, biology, physics.

[11]  Y. Shibamoto,et al.  Proliferative activity and micronucleus frequency after radiation of lung cancer cells as assessed by the cytokinesis-block method and their relationship to clinical outcome. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  N. Takai,et al.  Significance of fractionated irradiation for the biological therapeutic gain of carbon ions. , 2002, Radiation protection dosimetry.

[13]  M. Abe,et al.  Status of the clinical work at Hyogo. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  K. Sugimura,et al.  Acute morbidity of proton therapy for prostate cancer: the Hyogo Ion Beam Medical Center experience. , 2007, International journal of radiation oncology, biology, physics.

[15]  Lech Papiez,et al.  Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  岩田 宏満.  Estimation of errors associated with use of linear-quadratic formalism for evaluation of biologic equivalence between single and hypofractionated radiation doses : an in vitro study , 2010 .

[17]  L. Constine,et al.  Normal tissue toxicity after small field hypofractionated stereotactic body radiation , 2008, Radiation oncology.

[18]  A. Miller,et al.  Reporting results of cancer treatment , 1981, Cancer.

[19]  Susumu Kandatsu,et al.  Carbon Ion Radiotherapy for Stage I Non-small Cell Lung Cancer Using a Regimen of Four Fractions during 1 Week , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[20]  S Minohara,et al.  Respiratory gated irradiation system for heavy-ion radiotherapy. , 2000, International journal of radiation oncology, biology, physics.

[21]  S. Webb,et al.  Comparison of proton therapy and conformal X-ray therapy in non-small cell lung cancer (NSCLC). , 1999, The British journal of radiology.

[22]  H. Tsujii,et al.  Curative treatment of Stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen. , 2007, International journal of radiation oncology, biology, physics.

[23]  K. Nihei,et al.  High-dose proton beam therapy for Stage I non-small-cell lung cancer. , 2006, International journal of radiation oncology, biology, physics.

[24]  Harald Paganetti,et al.  Proton Beams to Replace Photon Beams in Radical Dose Treatments , 2003, Acta oncologica.

[25]  B. Jeremic,et al.  Radiation therapy alone in early stage non-small cell lung cancer. , 2003, Seminars in surgical oncology.

[26]  I. Kamae,et al.  Analysis of Vision loss caused by radiation-induced optic neuropathy after particle therapy for head-and-neck and skull-base tumors adjacent to optic nerves. , 2009, International journal of radiation oncology, biology, physics.

[27]  Branislav Jeremic,et al.  Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. , 2005, Lung cancer.

[28]  Mitsuyuki Abe,et al.  Preclinical biological assessment of proton and carbon ion beams at Hyogo Ion Beam Medical Center. , 2001, International journal of radiation oncology, biology, physics.

[29]  Masahiro Hiraoka,et al.  Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. , 2005, International journal of radiation oncology, biology, physics.

[30]  S. Senan,et al.  Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomy , 2009, Cancer.

[31]  H. Tsujii,et al.  Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer. , 2004, International journal of radiation oncology, biology, physics.

[32]  R. Pötter,et al.  Can protons improve SBRT for lung lesions? Dosimetric considerations. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[33]  Daniel W. Miller,et al.  Hypofractionated proton beam radiotherapy for stage I lung cancer. , 2004, Chest.

[34]  Hanne M Kooy,et al.  Target volume dose considerations in proton beam treatment planning for lung tumors. , 2005, Medical physics.

[35]  Tatsuaki Kanai,et al.  Examination of GyE system for HIMAC carbon therapy. , 2006, International journal of radiation oncology, biology, physics.

[36]  K. Johansson,et al.  Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer--mature results for medically inoperable patients. , 2006, Lung cancer.

[37]  Toshio Ohashi,et al.  Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm. , 2009, International journal of radiation oncology, biology, physics.

[38]  Angelika Hoess,et al.  Stereotactic single‐dose radiotherapy (radiosurgery) of early stage nonsmall‐cell lung cancer (NSCLC) , 2007, Cancer.